Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05842551 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prismatic Lenses and tDCS in Neglect

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 8, 2025 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 15, 2025 to Jul 15, 2026
    • Study completion date: Jul 15, 2025 to Dec 31, 2026
    v4
  2. Primary and study completion dates: Jul 30, 2024 to Jul 15, 2025v3
  3. Interventions: Rehabilitation combinatory treatment (Combination Product) to Prismatic adaptation and electric stimulation (Combination Product)
    • Eligibility criteria revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to to evaluate the effect and feasibility of a rehabilitation protocol with prismatic lenses associated with tDCS, compared to a prismatic lens rehabilitation protocol associated with sham stimulation, in reducing the signs of neglect in a group of patients with spatial heminegligence following ischemic stroke of the right hemisphere. The secondary objective is to evaluate the impact of this rehabilitation protocol on functional outcome.
Trial Details
NCT Number NCT05842551
Lead Sponsor Istituti Clinici Scientifici Maugeri SpA
Collaborators: Azienda USL Toscana Sud Est
Conditions
(from sponsor)		 Stroke, Ischemic
Related terms Ischemic Stroke, Stroke
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov